Could your aspirin be failing you? trinidad study investigates

NCT ID NCT06228820

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed pilot study looked at whether some healthy adults are resistant to aspirin's blood-thinning effects. 48 participants took two different types of 81 mg aspirin for two weeks each, and their platelet function was measured. The goal was to understand how common aspirin resistance is and how well lab tests can detect it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Aspirin (81 mg enteric-coated and 81 mg Vazalore aspirin)

What this could lead to

If successful, this could help identify why some people don't respond well to aspirin, potentially improving heart attack and stroke prevention strategies.

What could go wrong

This is a small pilot study with only 48 healthy participants, so results may not apply to the general population or those with medical conditions. The tests used are not perfectly accurate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLATELET DYSFUNCTION DUE TO DRUGS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

qualitative platelet defect

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of the West Indies

    Saint Augustine, North, 00000, Trinidad and Tobago